Coeptis Therapeutics Holdings Inc. reports corporate-status, capital-structure and biotechnology developments associated with the company that became Z Squared Inc. after a completed merger and name change. News tied to COEP includes shareholder voting matters, governance updates, operating and financial results, and material agreements.
The company’s biotechnology-related updates include clinical or regulatory disclosures and licensing activity involving majority-owned SNAP Biosciences, the SNAP-CAR NK cell therapy platform, and oncology applications using small-molecule adaptor technology. Later corporate updates center on capital structure, security-status changes and formal transaction disclosures.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.